Defects in innate immunity affect many different physiologic systems and several studies 33 of patients with primary immunodeficiency disorders demonstrated the importance of innate 34 immune system components in disease prevention or colonization of bacterial pathogens. To 35 assess the role of the innate immune system on nasal colonization with Staphylococcus aureus, 36 innate immune responses in pediatric S. aureus nasal persistent carriers (n=15) and non-37 carriers (n=15) were profiled by analyzing co-clustered gene sets (modules) identified through 38 large-scale transcriptome data analysis as the basis for the development of a targeted assay. 
Introductionto the clear differences in anti-S. aureus immune responses observed between persistent and 77 intermittent/non-carriers (18, 19) we examined the role of innate immune responses using high-78 throughput methods for transcript profiling. Our goal was to provide a better understanding of 79 which innate immune gene modules are associated with these distinct carriage profiles in a 80 pediatric cohort. 81
The successful assessment of innate immune responsiveness to respective pathogens 82 could result in the development of novel vaccines and new diagnostic tools for patients 83 presenting with recurrent and/or severe infections. We have previously reported on the design 84 of modules consisting of sets of coordinately expressed transcripts (29). The modular 85 framework has been successfully implemented in a wide range of studies, covering infections 86 and autoimmune diseases (30) (31) (32) . Recently, we reported on the creation of a set of modules 87 designed to further investigate gene profiles associated with innate immune activation signals 88 (33). The resulting 66 modules are divided into 7 clusters based on their response specificities; 89 some are specific for bacterial stimuli while others are specific for stimuli via a TIR (Toll-IL-1 90
receptor) domain. 91
Here we make use of the dimension-reduction concept we have developed for 92 microarray analysis and use it for gene selection for a focused qPCR-based assay in order to 93 develop a time-and cost-efficient tool that can be used to assess potential susceptibilities in 94 individual patients or groups. We used this targeted tool kit for the assessment of innate 95 immune response profiles of peripheral blood mononuclear cells (PBMCs) isolated from 96 pediatric S. aureus persistent and non-carriers stimulated with either i) a panel of TLR ligands, 97
ii) live S. aureus, or iii) heat-killed S. aureus. This analysis demonstrates that children who are 98 persistently colonized with S. aureus displayed a unique innate immune response profile to S. 99
aureus stimulation compared to non-carrier controls. Furthermore, the immune response elicited 100 in response to their specific S. aureus carriage strain was distinct from responses elicited by 101
The responses to the Carrier Strain and the Carrier Mix were, although not statistically 157 significant, slightly different both at a gene level (Fig. 6A ) and the module level (Fig. 6B ). Some 158 modules showed large donor-to-donor variation (e.g., M1.6, and M1.2) while others were 159 relatively stable across donors (e.g., M5.4, M4.3, and M8.2) pointing to the relative importance 160 of these modules following stimulation with bacterial antigens. When looking at the module 161 responses in an individual stimulated with the Carrier Mix compared to the response elicited 162 following stimulation with their respective carrier strain, small and subtle differences were 163 observed (Fig. 6B) . Although not statistically significant, these differences still may contribute to 164 the understanding persistent carriage of specific S. aureus isolates in these individuals. 165 PBMC responses to live or dead bacteria. Clear differences were observed in 166 responses elicited following stimulation with heat-killed S. aureus compared to stimulation with 167 live carriage isolates ( Fig. 7 and Table 4 ). Modules showing statistically significant differences in 168 gene expression profiles following stimulation with either heat-killed or live bacteria were 169 annotated as "Type I IFN" (M1.2, M2.2, M2.6, M5.4), "Inflammation" (M4.3, M8.4, M2.11), 170 "Apoptosis" (M4.4), "Transcriptional Regulation" (M7.4, M5.1, M2.10, M1.4), "Phagocytosis" 171 (M2.5, M8.2), or none or poorly defined annotations (M2.3, M2.13, M3.4, M4.7, M6.5, M7.5) . 172
Only 9 of 30 modules were not different following stimulation with either live or heat-killed 173 bacteria and 16 modules showed a consistent pattern in both carriers and non-carriers. In 174 addition, seven modules (M1.2, M1.4, M1.6, M2.6, M2.10, M4.7, and M5.1) showed small 175 differences to stimulation with live bacteria between carriers and non-carriers (Fig. 7) . Especially 176 interesting are the small differences observed in the expression profiles observed for modules 177 M1.4 and M1.6 (the two modules from the poly [I:C] specific cluster) that were up-regulated in 178 non-carriers stimulated with live bacteria, but down-regulated after heat-killed bacteria 179 stimulation. The expression profiles for these same modules were unchanged when PBMCs 180 harvested from persistent carriers were stimulated with either live or dead bacteria (Fig. 7) . (Fig. 8A) . Furthermore, differential expression of genes (Table 5 and Table S3 ) 193 and modules (Fig. 8B ) is greater following stimulation with live bacteria compared to stimulation 194 with heat-killed bacteria. Furthermore, non-carriers and persistent carriers differ in their module 195 responses and differences between persistent carriers and non-carriers detected by the 196 targeted assay are more pronounced when using RNAseq (Fig. 8C) . 197
We were next interested in identifying genes differentially activated in carriers and non-198 carriers. Because we hypothesized that differences would be minor due to our small data set, 199 we tried two different approaches aimed at identifying potential differences: (1) statistical testing 200 using a general linear model using negative binomial distribution with no random effects 201 (edgeR) and (2) measuring the "deviation from the perfect line" (the dot product). Any deviation 202 from this line could be due to a difference in responses to live bacteria in the different donor 203 groups. When applying these approaches to our data, 20 genes were identified as different 204 between carriers and non-carriers when using the statistical model (Table 6 ) and a total of 367 205 genes showed an altered profile for persistent carriers compared to non-carriers using this 206 "deviation from the perfect line" approach ( Fig. 9 and Table S4 ). The overlap between the two 207 different gene lists were rather low, only 5 genes were found with both methods (Table S4 ), but 208 the remaining genes were all close to the cutoff used for the "deviation from the perfect line". 209
210

Discussion 211
Interrogation of the human genome can be carried out by either conducting analyses that define 212 either its architecture or measure its output. Genome-wide association studies represent an 213 example of the former approach designed to identify genes or pathways that are determined by 214 heredity and do not change over time that may be associated with various immune-related, 215 chronic, and infectious diseases (35) (36) (37) (38) (39) (40) . By contrast, genetic approaches that measure 216 transcript abundance e.g. the TA, are largely affected by environmental stimuli such as 217 infection/colonization status. 218
The modular transcriptional repertoire analysis pioneered by our laboratories was used 219 as a basis for the development of the TA and used to identify differences in the transcriptome 220 between pediatric individuals determined to be either persistent nasal carriers or nasal non-221 carriers of S. aureus (29, 33, 41, 42) . The module concept is based on co-expression of genes 222 that may or may not be related and individual genes represented in respective modules may not 223 necessarily be directly involved with the function of the modules. This assay is meant to be 224 analyzed and interpreted at the modular level where individual genes comprising each module 225 contribute to a profile that can be used to understand potential defects in innate immune 226 responsiveness, not as a tool to pinpoint the exact gene responsible for respective phenotypes. 227
The modules used in the present study were specifically developed for analyses of 228 stimulated whole blood (33), but the underlying framework is the same as what has been 229 previously described (41). More importantly, the TA described in the present report allowed for 230 frozen PBMCs to be analyzed, producing results indistinguishable from similarly treated fresh 231 whole blood. Also, the time and cost reduction that comes by using the TA makes it a very good 232 first screening tool, especially when there are many samples to process. 233
The advantage the modular approach which the TA described here is based on is 234
highlighted by prior work that identified a type I interferon signature in association with systemic 235 lupus erythematosus not previously identified using traditional approaches (43) (44) (45) This analysis also uncovered differences in gene expression profiles between persistent carriers 286 and non-carriers. Specifically, unique process networks for non-carriers were related to IL-1 and 287 IL-6 signaling, apoptosis, inflammasome related regulators, and inflammation compared to IL-5 288 signaling, apoptosis, and basophil related processes associated with persistent carriers. This 289 suggested that persistent carriers may have alterations in their ability to respond to Vita-PAMPs 290 (pathogen associated molecular patterns) that may have facilitated persistent colonization with 291
S. aureus (34, 49). 292
Vita-PAMPs are closely related to PAMPs in that they activate the innate immune 293 system following recognition by the host's pattern recognition receptors (PRRs), e.g. Toll-like 294 receptors (TLRs), but differ in that they serve as microbial signatures of viability, e.g. bacterial 295 mRNA, pyrophosphates, quorum sensing molecules, bacterial second messengers, and 296 isopyrenoids resulting in heightened innate immune activation (34, 49, 50) . For example, 297 phagocytosis of live pathogens expressing both PAMPs and Vita-PAMPs, but not dead 298 pathogens expressing PAMPs alone, resulted in the activation of a TRIF-dependent signaling 299 pathway that triggered inflammasome activation and subsequent caspase-1 mediated 300 production of INF (34). Activation of the inflammasome eventually results in a highly 301 inflammatory form of cell death (pyroptosis) that is beneficial to pathogen containment/clearance 302 since the release of endocytosed organisms results in more efficient clearance by neutrophils 303
(51). 304
TLRs and other PRRs are the 'guardians at the gate' that define whether or not an 305 immune response will be initiated, and depending on the nature of the stimulus these receptors 306 will alter the type and quality of the adaptive response that develops. Ten TLRs have been 307 described in humans and each TLR homodimer or heterodimer combination (e.g., TLR1:TLR2 308 and TLR2:TLR6) recognize unique PAMPs. All TLRs described to date utilize the MyD88/MAL 309 signaling adaptor molecules with the exception of TLR4 that can also bind to the TRIM/TRAM 310 adaptor molecule complex at the membrane of endosomal compartments (52); however, data 311 suggested that TRIM/TRAM can also serve as an adaptor protein in TLR2:TLR6 signaling (53). dichotomy are data demonstrating that almost half of mice deficient in TLR4 died from an S. 320 aureus infection suggesting that both TLR2 and TLR4 are important to abscess containment in 321 addition to coordination of the T-cell response and mediating wound healing (55). In addition, 322 TLR4 knockdown modulated the inflammatory response to S. aureus by down-regulating TNF 323 concentrations suggesting that both TLR2 and TLR4 contributed to the anti-S. aureus response 324 (56, 57). 325
Our results suggested that although there are no or only few statistically significant 326 differences between responses observed between persistent carriers and non-carriers following 327 stimulation with either TLR ligands or bacteria, our data indicate that there may be potential 328 alterations in the previously described Vita-PAMP pathway among S. aureus persistent carriers. 329
These alterations appear to be localized to the TRIF/TRAM-related pathway suggested to be 330 part of the recognition of live versus dead bacteria (58). The implications of these potential 331 differences in TRIF/TRAM-related pathway activation between persistent carriers and non-332 carriers indicated that although the persistent carriers included in this study are fully capable of 333 recognizing and responding to TLR ligands and dead bacteria, their responses to live bacteria 334 are different and may be a determinant for persistent colonization with this organism. 335 336 337
Materials and Methods 338
Study population and sample collection. Pediatric patients at the Northwest 339
Assistance Ministries Clinic, Houston, TX, located in northwestern Harris County were eligible 340
for participation in the current study if they were participants of a prior parent study investigating 341 pediatric S. aureus nasal carriage (n=438). In the parent study, we established nasal carriage 342 phenotypes (persistent, intermittent, or non-carriers) based on the identification of S. aureus on 343 2 consecutive nasal swabs collected 12-17 days apart, based on the 2-culture method 344 previously described (16, 17, 25, 59) . Participants in the parent study testing positive for S. 345 aureus on both swabs were classified as persistent carriers. Non-carriers were S. aureus 346 negative at both time points and intermittent carriers were positive for one of the two initial 347 swabs collected. No intermittent carriers are included in the present study. Using univariate 348 statistics, we compared demographic characteristics between the two patient groups, using the 349 chi-squared test for categorical variables (Fisher's exact p-value if the comparison included a 350 frequency ≤5) or ANOVA for continuous variables, using Stata 14 (Table 1 ) (College Station, 351
TX). 352
Confirmatory third swabs were conducted on participants from the parent study until 15 353 persistent and 15 non-carriers of S. aureus were identified and also agreed to participate in the 354 present study. Confirmatory third swabs were collected between 6-931 days after the second 355 swab (median 207 days) ( Table 2 ) and processed for the detection of S. aureus as described 356 previously (16, 59, 60) . S. aureus isolates from 12 of the 15 persistent carriers were available for 357 analysis in the current study, and they were used individually (denoted "Carrier Strain") and 358 combined (denoted "Carrier Mix"). In all, a persistent carrier could have up to 6 S. aureus 359 positive cultures from the 3 swabs collected at different time points (Table 2) . 360
Peripheral blood was drawn into ACD Vacutainer  tubes from participants enrolled in the 361 study using standard phlebotomy techniques. Specimen tubes were labeled and transported at 362 (Table 3 and Table S1 ). The selected modules span a wide variety of 377 cellular and immune functions including inflammation, the production of type I and II IFNs and 378 other cytokines such as IL-1, IL-6, and IL-10, cytokines associated with apoptosis, caspase 379 expression and FAS signaling, and cytokines associated with cell 380 signaling/adhesion/chemotaxis. These functions are critical to the activation of innate immune 381 responses. The mean, standard deviation, and coefficient of variation (cv) of the expression 382 values for each probe across all donors were calculated and 6 probes with a low cv and means 383 spanning the width of the expression values were selected as housekeeping genes (Table 3) . In 384 short, we used a data-driven approach to select 30 modules, 3 genes per module and 6 385 housekeeping genes that when combined, capture the same overall module signature as a full 386 microarray or RNAseq (Table 3 and Table S1 ). 387
Microarray analyses. Microarray analyses were carried out as part of the method 388 development in order to compare the module signature between a full microarray and the TA. 389
Frozen PBMCs from adult donors (n = 8, females, 21-60 years old) were treated as described in 390 in the preceding section. The RNA from each sample was split and used for both microarray 391 analysis and the TA as described above. Biotinylated cRNA targets were prepared from 250 ng 392 of total RNA using the Illumina TotalPrep RNA Amplification Kit (Ambion, ThermoFisher 393 Scientific). Labelled cRNA (750 ng) was then incubated for 16 h with HT-12 v4 BeadArrays 394 (48,323 probes). Beadchip arrays were then washed, stained, and scanned on an Illumina 395 HiScanSQ according to the manufacturer's instructions. 396
Following background subtraction, raw signal values extracted with Illumina Beadstudio 397 (version 2) were scaled using quantile normalization. Minimum intensity was set to 10 and all 398 the intensity values were log 2 transformed. Only the probes called 'present' in at least one 399 sample (p<0.01) were retained for downstream analysis (n=19,624). 400
Transcripts differentially regulated upon stimulation were defined based on a minimum 401 2-fold change (up-or down-regulation) and a minimum absolute raw intensity difference of 100 402 compared to respective unstimulated samples. Heatmaps were generated using R (version Correlations between individual modules and module clusters between microarray and 413 TA were performed using the Spearman Rank Correlation on log 2 FC values. Differentially-414 expressed genes and modules between PBMCs isolated from carriers and non-carriers 415 stimulated with either live or dead bacteria were tested using the Student's t-test and the 416 Fligner-Killeen test was used to test variance. Differences between genes and modules 417 between a commercial S. aureus strain, the unique carrier strain, and the mix of all unique 418 carrier strains were tested using paired t-tests and the paired variance test. All p-values were 419
False Discovery Rate (FDR) adjusted. All analyses were done in R (version 3.4.1). 420
Test of Targeted assay robustness. The robustness of the TA was tested using whole 421 blood, fresh PBMCs, and frozen PBMCs from the same blood draw from healthy adult 422 volunteers (n = 4) at Benaroya Research Institute (Seattle, WA). From each blood sample 423
(within 4 h of collection), 500 µl whole blood was diluted in 500 µl of RPMI containing respective 424 stimuli in 48-well plates (Corning, Glenview, IL). The remaining blood was immediately used for 425
PBMC isolation using Ficoll Paque plus (GE Healthcare, Littler Chalfont, U.K.). The isolated 426
PBMCs were split in two, one half being used immediately and the other half frozen in 7% 427 DMSO in fetal bovine serum and cooled at -1°C/min in a freezing container (Nalgene, 428
ThermoFisher Scientific). Freshly isolated PBMCs were plated in 96 deep-well plates (Greiner 429
Bio-One, Monroe, NC) at a concentration of 1x10 6 cells/ml with a total of 0. PenStrep (Sigma), and 1 mM sodium pyruvate (Sigma) and rested overnight at 37°C with 5% 437 CO 2 before adding respective stimuli. 438 PBMCs (freshly isolated and previously frozen) and fresh whole blood were each 439 stimulated for either 2 or 6 h with (1) PMA/ionomycin (Sigma) (PBMC: 2.5 ng/ml PMA, 0.1 µg/ml 440 ionomycin; whole blood: 25 ng/ml PMA; 1 µg/ml ionomycin, (2) IFNα (3x10 4 units/ml, R&D 441 Systems, Minneapolis, MN), (3) TNFα (20 ng/ml, R&D Systems), (4) IL-1β (PBMC: 2 ng/ml, 442 whole blood: 20 ng/ml, R&D Systems), (5) PAM3CSK4 (10 ng/ml, InvivoGen, San Diego, CA), 443 (6) poly (I:C) (25 µg/ml, InvivoGen), (7) LPS (100 ng/ml, InvivoGen), (8) R848 (300 ng/ml, 444 InvivoGen), (9) CpGC (1.75 µM, InvivoGen), (10) heat-killed Staphylococcus aureus (10 7 445 cells/ml, Staphylococcus aureus subsp. aureus Rosenbach (ATCC® 6538™), or (11) un-446 stimulated for the same 2 or 6 h time period at 37°C with 5% CO 2 . Cells were then washed and 447 lysed using RLT buffer (Qiagen, Germantown, MD) supplemented with 1% β-mercaptoethanol 448 (Sigma) and whole blood was lysed with Tempus solution (Tempus Blood RNA tubes, 449
ThermoFisher Scientific) to stabilize the RNA at 1:3 ratio. Cell/whole blood lysates were stored 450 at -80°C until RNA extraction was conducted. 451 Pediatric S. aureus carriage in vitro PBMC stimulation. Blood was collected at the 452 Northwest Assistance Ministries Clinic (Houston, TX) and PBMCs were isolated from whole 453 blood within 4 h of collection using Ficoll Paque plus (GE Healthcare) and frozen down in 7% 454 DMSO in fetal bovine serum and cooled at -1°C/min in a freezing container (Nalgene, 455 ThermoFisher Scientific). Frozen PBMCs were stored at -80°C before shipping on dry ice to 456
Benaroya Research Institute for further processing and stimulation as described above. 457 Pediatric PBMCs were stimulated for 6 h with (1) TNF (20 ng/ml, R&D Systems), (2) 458 heat-killed S. aureus (10 7 cells/ml, InvivoGen), (3) S. aureus (10 7 cells/ml) isolated from the 459 subject's own nasal swab ("Carrier Strain") (i.e., only carriers were stimulated using their own 460 carriage isolate), (4) a mixture (10 7 cells/ml) of all S. aureus isolates obtained from carrier 461 subjects ("Carrier Mix"), (5) IL-1β (2 ng/ml, R&D Systems), (6) PAM3CSK4 (10 ng/ml, 462 InvivoGen), (7) CpG (1.75 µM, InvivoGen), or (8) un-stimulated, for the same time period. Due 463 to the limited cell numbers that could be obtained from each pediatric donor, each treatment and 464 control group/participant were carried out as singletons. After the incubation period, cells were 465 washed with PBS and lysed using RLT buffer (Qiagen) supplemented with 1% β-466 mercaptoethanol (Sigma). Cell lysates were stored in -80°C until RNA extraction. 467 RNA extraction and the targeted assay. RNA was extracted from PBMCs using the 468 RNeasy Mini Kit (Qiagen) and from blood tempus mix tubes using MagMAX™-96 Total RNA 469
Isolation Kit (Applied Biosystems, ThermoFisher Scientific). RNA integrity was assessed on an 470
Agilent 2100 Bioanalyzer (Agilent, Palo Alto, CA). 471
After conversion of RNA to cDNA (50 ng total RNA from PBMCs and 100 ng total RNA from 472 WB) (no globin reduction was performed) targeted genes were amplified and analyzed with Fast 473
Gene Expression Analysis using EVAGreen® on the BioMark™ HD System (Fluidigm, San 474
Francisco, CA). 475
Raw CT values were exported from Fluidigm Real-Time PCR Analysis (version 3.1.3) and 476
CT and CT values were calculated using R (version 3.4.1). Genes or samples that had a fail 477 call rate of 50% or more were excluded from downstream analyses (all samples and genes 478 passed this criteria in the experiments included in this study). 479
Transcripts differentially regulated upon stimulation were defined based on a minimum 2-480 fold change (up-or down-regulation) compared to respective unstimulated samples. Heat maps 481 were generated using R (version 3.4.1). 482 RNA sequence processing. RNAseq was performed on a representative subset of the 483 samples from the respective S. aureus carriage phenotype groups. A total of 6 donors, 3 484 carriers (2 females and 1 male ages 4, 5, and 10 years, respectively) and 3 non-carriers (2 485 females, 1 male, ages 2, 4, and 11 years) treated with heat-killed S. aureus or a mixture of all 486 collected carrier strains as described above (together with their untreated matched samples) 487 were analyzed. 488
Sequencing libraries were constructed from total RNA using TruSeq RNA Sample 489 Preparation Kits v2 (Illumina, San Diego, CA). Libraries were clustered onto a flowcell using a 490 cBOT amplification system with a HiSeq SR v3 Cluster Kit (Illumina). Single-read sequencing 491 was carried out on an Illumina HiScanSQ sequencer using a HiSeq SBS v3 Kit to generate 100-492 base single-end reads with a target of approximately 10 million reads per sample. The raw 493 reads were processed in Galaxy, using TopHat (with bowtie) for alignment (GRCh37 as 494 reference genome), BAM-to-SAM, Picard Alignment Summary Metrics, and Picard RNAseq 495
Metrics. Genes were quantified using htseq-count. RPKMs for genes were obtained using 496 edgeR (61, 62) . 497
RNAseq analysis. Raw counts were used for downstream analysis and Fragments Per 498
Kilobase Million (FPKM) values were used for plotting. To identify differentially-expressed 499 genes, a general linear model using negative binomial distribution with no random effects was 500 applied using edgeR (61-63). Genes having an FDR <0.05 were considered differentially 501
expressed. 502
Defining altered responses to live bacteria was done in one of two ways: (1) shared Ensembl IDs and were dealt with as follows: i) multiple probes/Ensembl Gene IDs all in 514 the same module were kept as one input and ii) multiple probes/Ensembl Gene ID in different 515 modules can appear in multiple different modules. This was done to avoid picking the "best" fit. 516
To determine if a gene was expressed or not in a particular module for the TA, fold change 517 cutoffs were applied (log 2 FC > ±2) and for the RNAseq data, the DEG cutoff FDR<0.05 was 518
used. 519
Data availability. The data described in this publication have been deposited in NCBI's 520
Gene Expression Omnibus (64) and the full modular transcriptome repertoire (66 modules) from the full microarray from the 8 557 healthy adults used for method development. The module responses between TA and 558 microarray subset to TA genes are identical. The full 66 modules show the same characteristics 559 expected from (33): module cluster 2 is poly (I:C) specific, module cluster 5 is bacterial specific, 560 module cluster 3 is non-specific, and the remaining clusters are TIR and bacterial specific. The 561 module response pattern seen in the full 66 modules can be seen in both TA and the microarray 562 subset. <0.05 in at least one donor group (live bacteria vs. non-stimulated) (n = 367). Three groups of 648 genes can be identified based on the cutoffs they pass: A: 2*SD and FDR<0.05 for both non-649 carriers and carriers (red points, n = 60), B: 2*SD and FDR<0.05 for non-carriers but not 650 persistent carriers (green points, n= 198), C: 2*SD and FDR<0.05 for persistent carriers but not 651 non-carriers (blue points, n = 109). 652 653 
672
*Modules statistically significant between persistent carriers and non-carriers (Table 4) . 673 A list of all the genes in respective modules is provided in Table S1 . 674 675 Table 6 and Figure 9 . 
